Pharmacogenomic Testing for SSRIs: How CYP2C19 and CYP2D6 Affect Side Effects
17
Mar
Gregory Sterling
11
Pharmacogenomic testing for CYP2C19 and CYP2D6 genes helps predict how your body processes SSRIs, reducing side effects and avoiding trial-and-error prescribing. Learn who benefits most and what the science really says.